Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (2016YFC0901500)
the Center for Rare Diseases Research, Chinese Academy of Medical Sciences (2016ZX310174-4)
- License Information
-
More Information
Article History
Received: 24 March 2022
Accepted: 10 November 2022
First Online: 23 November 2022
Declarations
:
: The authors declare that they have no conflict of interest.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Both the institutional review board ethics committee of the Chinese University of Hong Kong and Peking Union Medical College Hospital approved the study protocol and informed consent (Ref No. SBRE-18-268 and SK814).
